Just Other Articles

Certainly age discrimination exists out there in the cold cruel work world and, as a result, 50-something executives and managers might not want to throw out thei

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

r Grecian Formula just yet. But might there be a, excuse the expression, “silver lining” to slowing economic times when it comes to all those middle-agers suddenl

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

y cast out there onto the tightening job market? According to a survey from Challenger, Gray and Christmas, the Chicago-based outplacement firm, there may very we

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ll be.

In a comparative look at jobless professionals possessing 10 years or more experience in managing, the firm learned that such job-hunters required only 2.

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

months to find a new job in the fourth quarter of last year vs. 3.7 months in the final quarter of 1999, just one year earlier. Since the typical jobless candida

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

te Challenger studied was 46 years old, with 8 years at his or her last position, earning $78,000/year on average, the implications for reverse-ageism are signifi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

cant.

“Perhaps what we are seeing is that companies, anticipating an ongoing slowdown, are stocking up on the individuals they feel will best lead them through t

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e downturn,” surmised John Challenger, the company’s chief executive. “Employers may be recognizing that this person, with 20-plus years work experience, has been

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

through bad times before and that prior experience will be extremely valuable in navigating the current slump.”

So hard experience, suddenly, “comes of age.” Th

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

e heck with all those too-hip, geek-faced dot-commers who just a few short months ago appeared to be assuming the mantel of all things bright and business-like. W

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

iz Kid is now getting passed over in favor of Grayheads and paunched-out “Old Reliables.” Life certainly has its way of concocting intriguing ironies.

If we pee

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

r a mite closer however, irony, apparently, it’s not. Common sense, as in “a return to…” seems more like it. As we let our business selves run amok the last few

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

years, partying our brains out amid the most explosive, exciting, outrageous and expansive boom time in the history of any civilization, we installed blinding sta

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

rs in our eyes aimed toward every front. Whether it was high employment, low-low interest rates, skyrocketing stock yields, or little or no inflation, we ate it u

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

, chewed it up, gulped it down and cried out for more. Never, never-ever, we believed, would this feast ever stop.

Now suddenly out of nowhere, our reality check

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

— the banquet has ended, the feeding frenzy has run out of gas. It’s a slowing economy, falling stock market, even corporate layoffs rearing their ugly old heads

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

again. The “gid” times (as in “giddiness”) are over.

It stands thus to reason that even the most marginally intelligent management teams would recognize that the

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

high times didn’t, in the end, bring us all that far, and that means maturity and coolness become high values as a follow-up, not brash energy and cautions-to-the

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

-winds. Now the old family doctor prescribes maturity, reasoned thinking, decision-making experience and a sprinkling of deep-career seasoning. For those knowledg

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

eable, wise management practitioners who have hung in there with their employers over the years in high times and bad, happy days are here again.

And vindication

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/18999/justotherarticles-Is-the-Slowing-Economy-GOOD-for-Older-Managers.html">Is the Slowing Economy GOOD for Older Managers?</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/18999/justotherarticles-Is-the-Slowing-Economy-GOOD-for-Older-Managers.html]Is the Slowing Economy GOOD for Older Managers?[/url]

What Is MICR? Here's a concise guide to MICR and associated technologies. By Charles Katz Magnetic Ink Character Recognition (MICR) was developed to utilize the benefits of computer technology in the...

Most people find financial statements identical to a foreign language. To ensure that financial statements are easier to understand, there is a set of rules and practices known as the generally accepted accounting principles (GAAP). Development of these rules provides a basic guideline accounting because I think it’s fair to say that it can get obtuse at times.

Tags

Links

Just Other Articles - Is the Slowing Economy GOOD for Older Managers?

Related Articles: